EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Simultaneously Targeting Two Coupled Signalling Molecules in the Mesenchymal Stem Cell Support Efficiently Sensitises the Multiple Myeloma Cell Line H929 to Bortezomib

P M Rojas-Zambrano iD, J E Meyer-Herrera iD, P F Ruiz-Aparicio iD, J P Vernot iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24098157 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von P M Rojas-Zambrano und 3 weiteren Autor:innen. Beteiligte Einrichtung: Grupo de Investigación Fisiología Celular y Molecular, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá 111321, Colombia. Hauptthemen laut MEDLINE: Multiple Myeloma, Mesenchymal Stem Cells. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Faculty of Medicine, Universidad Nacional de Colombia and Dirección Investigación Extensión Bogotá (DIEB), The Dirección Investigación Extensión Bogotá (DIEB), Faculty of Medicine, Universidad Nacional de Colombia, Bogotá (Project 51259 to JPV).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Several studies have shown that diverse components of the bone marrow (BM) microenvironment play a central role in the progression, pathophysiology, and drug resistance in multiple myeloma (MM). In particular, the dynamic interaction between BM mesenchymal stem cells (BM-MSC) and MM cells has shown great relevance. Here we showed that inhibiting both PKC and NF-κB signalling pathways in BM-MSC reduced cell survival in the MM cell line H929 and increased its susceptibility to the proteasome inhibitor bortezomib. PKC-mediated cell survival inhibition and bortezomib susceptibility induction were better performed by the chimeric peptide HKPS than by the classical enzastaurin inhibitor, probably due to its greatest ability to inhibit cell adhesion and its increased capability to counteract the NF-κB-related signalling molecules increased by the co-cultivation of BM-MSC with H929 cells. Thus, inhibiting two coupled signalling molecules in BM-MSC was more effective in blocking the supportive cues emerging from the mesenchymal stroma. Considering that H929 cells were also directly susceptible to PKC and NF-κB inhibition, we showed that treatment of co-cultures with the HKPS peptide and BAY11-7082, followed by bortezomib, increased H929 cell death. Therefore, targeting simultaneously connected signalling elements of BM-MSC responsible for MM cells support with compounds that also have anti-MM activity can be an improved treatment strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaMesenchymal Stem CellsHumansBortezomibNF-kappa BCell Line, TumorTumor Microenvironment

Stichwörter der Autor:innen

BAY11-7082HKPSNF-κBPKCbortezomibcell adhesiondrug susceptibilitymesenchymal stem/stromal cellsmicroenvironmentmultiple myeloma

Substanzen

BortezomibNF-kappa B

Autor:innen und Institutionen

  • Grupo de Investigación Fisiología Celular y Molecular, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá 111321, Colombia.
  • Instituto de Investigaciones Biomédicas, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá 111321, Colombia.

ORCID-Profile: P M Rojas-Zambrano, J E Meyer-Herrera, P F Ruiz-Aparicio, J P Vernot

Förderung

  • Faculty of Medicine, Universidad Nacional de Colombia and Dirección Investigación Extensión Bogotá (DIEB)
  • The Dirección Investigación Extensión Bogotá (DIEB)
  • Faculty of Medicine, Universidad Nacional de Colombia, Bogotá (Project 51259 to JPV)

Zitieren

APA

Rojas-Zambrano, P. M., Meyer-Herrera, J. E., Ruiz-Aparicio, P. F., & Vernot, J. P. (2023). Simultaneously Targeting Two Coupled Signalling Molecules in the Mesenchymal Stem Cell Support Efficiently Sensitises the Multiple Myeloma Cell Line H929 to Bortezomib. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24098157

Vancouver

Rojas-Zambrano PM, Meyer-Herrera JE, Ruiz-Aparicio PF, Vernot JP. Simultaneously Targeting Two Coupled Signalling Molecules in the Mesenchymal Stem Cell Support Efficiently Sensitises the Multiple Myeloma Cell Line H929 to Bortezomib. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24098157

BibTeX
@article{RojasZambrano2023,
  author = {Rojas-Zambrano, P M and Meyer-Herrera, J E and Ruiz-Aparicio, P F and Vernot, J P},
  title = {Simultaneously Targeting Two Coupled Signalling Molecules in the Mesenchymal Stem Cell Support Efficiently Sensitises the Multiple Myeloma Cell Line H929 to Bortezomib},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24098157}
}
Kostenlos starten →